Functional Assessment of Fatigue and Other Patient-Reported Outcomes in Patients Enrolled in the Global aHUS Registry
This longitudinal studyassessedfatigue and treatment status in patients with Atypical hemolytic uremic syndrome (aHUS) from the Global aHUS Registry. The results confirm the detrimental effects of aHUS on patients’ daily lives, especially in terms of fatigue,butdemonstratessignificant improvement in symptoms following treatment with eculizumab.